SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001232524-12-000087
Filing Date
2012-11-09
Accepted
2012-11-08 18:57:34
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q jazz2012q3doc.htm 10-Q 1536854
2 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq32012ex311.htm EX-31.1 13259
3 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq32012ex312.htm EX-31.2 12233
4 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 jazzq32012ex321.htm EX-32.1 7934
  Complete submission text file 0001232524-12-000087.txt   11405899

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT jazz-20120930.xml EX-101.INS 1814556
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20120930.xsd EX-101.SCH 83474
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jazz-20120930_cal.xml EX-101.CAL 125437
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jazz-20120930_def.xml EX-101.DEF 546440
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20120930_lab.xml EX-101.LAB 923710
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20120930_pre.xml EX-101.PRE 585493
Mailing Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4
Business Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4 353-1-634-4183
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 121191315
SIC: 2834 Pharmaceutical Preparations